Menu

PTC Therapeutics, Inc. PTCT

Full chart Compare
Set alert

Price alert · PTCT

All alert types
65.44 USD -0.23 (-0.35%)

At closeNov 6, 2026, 7:38 PM EST

65.39 -0.05 -0.08%

After hours · Nov 6, 7:38 PM ET

65.18 Day range 66.67
59.24 52-week range 89.55
YTD
-13.85%
1 year
-9.85%

Revenue & Expenses

Revenue → Gross Profit: $1.66BGross Profit → Net Income: $682.64MGross Profit → Selling, General & Admin: $347.14MGross Profit → Research & Development: $455.25MRevenue → Cost of Revenue: $71.75MGross Profit → Interest Expense: $152.23MGross Profit → Other Expenses: $7.66MGross Profit → Income Tax: $13.97MGross Profit$1.66BCost of Revenue$71.75MNet Income$682.64MSelling, General & Admin$347.14MResearch & Development$455.25MInterest Expense$152.23MOther Expenses$7.66MIncome Tax$13.97MRevenue$1.73B

Latest period ending Dec 31, 2025 · select a line to chart its full history

PTCT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.73B806.78M937.82M698.80M538.59M
1.68B749.38M872.34M654.12M506.26M
866.13M-307.05M-567.20M-473.31M-374.94M
682.64M-363.30M-626.60M-559.02M-523.90M
7.78-4.73-8.37-7.79-7.43
PTCT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
984.65M779.71M594.00M279.83M189.72M
2.90B1.71B1.90B1.71B1.94B
3.10B2.80B2.71B2.05B1.94B
398.70M389.30M415.03M703.63M535.38M
-205.31M-1.10B-818.55M-347.09M1.44M
PTCT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
711.20M-107.69M-158.42M-356.65M-251.33M
-861.98M44.18M-176.74M290.18M219.18M
331.09M255.87M646.40M167.95M20.88M
-8.79M171.55M-28.44M-32.02M-28.21M
203.02M185.03M314.36M98.71M-19.09M